|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV033962456 |
| 003 |
DE-627 |
| 005 |
20230624001932.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2014 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/S0378-3782(14)70010-6
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2014012000026.pica
|
| 035 |
|
|
|a (DE-627)ELV033962456
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(14)70010-6
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Zavattoni, Maurizio
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Diagnosis and counseling of fetal and neonatal HCMV infection
|
| 264 |
|
1 |
|c 2014
|
| 300 |
|
|
|a 3
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Fetal HCMV infection is investigated by amniocentesis when a maternal primary infection is diagnosed or ultrasound (US/MRI) abnormalities are observed. In fetal blood, prognostic markers of symptomatic congenital infection may be evaluated for parental counseling. At birth, viral load measurement in body fluids may correlate with long-term sequelae, but the prognostic accuracy of symptomatic infection increases when maternal, fetal, and neonatal parameters are combined.
|
| 650 |
|
7 |
|a Prognostic markers
|2 Elsevier
|
| 650 |
|
7 |
|a HCMV
|2 Elsevier
|
| 650 |
|
7 |
|a Congenital infection
|2 Elsevier
|
| 700 |
1 |
|
|a Furione, Milena
|4 oth
|
| 700 |
1 |
|
|a Arossa, Alessia
|4 oth
|
| 700 |
1 |
|
|a Iasci, Angela
|4 oth
|
| 700 |
1 |
|
|a Spinillo, Arsenio
|4 oth
|
| 700 |
1 |
|
|a Lombardi, Giuseppina
|4 oth
|
| 700 |
1 |
|
|a Stronati, Mauro
|4 oth
|
| 700 |
1 |
|
|a Righini, Andrea
|4 oth
|
| 700 |
1 |
|
|a Baldanti, Fausto
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:90
|g year:2014
|g pages:29-31
|g extent:3
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/S0378-3782(14)70010-6
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 90
|j 2014
|h 29-31
|g 3
|y 90.2014, S29-, (3 S.)
|
| 953 |
|
|
|2 045F
|a 610
|